This chemical is primarily utilized in the pharmaceutical and organic synthesis industries. It serves as a key intermediate in the production of various active pharmaceutical ingredients (APIs), particularly those targeting neurological and psychiatric disorders. Its structure, featuring both an amino and a fluorine group, makes it valuable for creating compounds with enhanced biological activity and selectivity. Additionally, it is employed in the development of fluorinated aromatic compounds, which are often used in drug discovery due to their metabolic stability and improved binding affinity to target proteins. Its ester functionality also allows for further chemical modifications, enabling the synthesis of a wide range of derivatives for research and therapeutic applications.